首页> 外文OA文献 >Complications of endomyocardial biopsy in heart transplant patients: a retrospective study of 2117 consecutive procedures
【2h】

Complications of endomyocardial biopsy in heart transplant patients: a retrospective study of 2117 consecutive procedures

机译:心脏移植患者心内膜活检的并发症:2117例连续手术的回顾性研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUND: Endomyocardial biopsy (EMB) remains the gold standard for the diagnosis of graft rejection after heart transplantation (HT). Our purpose was to evaluate the rate of complications of this invasive procedure.METHODS: This was a retrospective study of 175 patients, who were transplanted between November 2003 and October 2010 and survived more than 1 month after surgery. We evaluated the number of inconclusive EMB and described the incidence, nature, and subsequent management of several complications associated with this procedure.RESULTS: Over a period of approximately 7 years, we performed 2217 EMB yielding 4972 specimens, namely, an average of 2.3 fragments per procedure. The majority of EMBs (95.3%) were performed by the femoral approach. Only 12 EMB (0.57%) were inconclusive. The overall complication rate was 0.71%. During puncture, one patient experienced a vasovagal reaction and another one, a femoral artery false aneurysm. During the biopsy, there was one case of cardiac perforation with tamponade, two cases of supraventricular tachycardia, and three atrioventricular conduction abnormalities. In 19 patients, histological analysis revealed chordal tissue, but only two patients developed mild tricuspid regurgitation. We observed five cases of coronary artery fistulae. The clinical outcomes were favorable in all cases.CONCLUSION: EMB proved to be a suitable, safe method to monitor rejection after HT.
机译:背景:心内膜活检(EMB)仍然是诊断心脏移植(HT)后移植排斥反应的金标准。我们的目的是评估这种侵入性手术的并发症发生率。方法:这是对175例患者的回顾性研究,这些患者在2003年11月至2010年10月之间移植,并在手术后存活了1个月以上。我们评估了不确定的EMB的数量,并描述了与此过程相关的几种并发症的发生率,性质和后续处理。结果:在大约7年的时间里,我们进行了2217个EMB,产生了4972个样本,即平均2.3个碎片每个过程。大多数EMB(95.3%)通过股骨入路进行。只有12个EMB(0.57%)没有定论。总体并发症发生率为0.71%。穿刺过程中,一名患者经历了血管迷走神经反应,另一名患者经历了股动脉假性动脉瘤。活检期间,有1例心脏穿孔并有填塞,2例室上性心动过速和3例房室传导异常。在19例患者中,组织学分析显示了腱组织,但只有2例患者出现了轻度三尖瓣关闭不全。我们观察了五例冠状动脉瘘。结论:EMB被证明是监测HT后排斥反应的一种合适,安全的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号